Amphastar Pharmaceuticals Inc (AMPH)
42.46
-0.20
(-0.47%)
USD |
NASDAQ |
May 03, 16:00
42.43
-0.03
(-0.07%)
After-Hours: 20:00
Amphastar Pharmaceuticals Total Liabilities (Quarterly): 873.49M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 873.49M |
| September 30, 2023 | 949.49M |
| June 30, 2023 | 789.03M |
| March 31, 2023 | 225.08M |
| December 31, 2022 | 213.33M |
| September 30, 2022 | 221.53M |
| June 30, 2022 | 224.41M |
| March 31, 2022 | 236.71M |
| December 31, 2021 | 226.01M |
| September 30, 2021 | 221.50M |
| June 30, 2021 | 198.52M |
| March 31, 2021 | 194.78M |
| December 31, 2020 | 182.51M |
| September 30, 2020 | 162.76M |
| June 30, 2020 | 157.62M |
| March 31, 2020 | 149.46M |
| December 31, 2019 | 159.44M |
| September 30, 2019 | 151.98M |
| June 30, 2019 | 169.01M |
| March 31, 2019 | 164.45M |
| December 31, 2018 | 149.20M |
| Date | Value |
|---|---|
| September 30, 2018 | 139.37M |
| June 30, 2018 | 131.12M |
| March 31, 2018 | 122.68M |
| December 31, 2017 | 117.34M |
| September 30, 2017 | 107.11M |
| June 30, 2017 | 110.68M |
| March 31, 2017 | 110.05M |
| December 31, 2016 | 98.48M |
| September 30, 2016 | 100.38M |
| June 30, 2016 | 101.12M |
| March 31, 2016 | 98.42M |
| December 31, 2015 | 94.63M |
| September 30, 2015 | 111.24M |
| June 30, 2015 | 113.66M |
| March 31, 2015 | 117.22M |
| December 31, 2014 | 107.51M |
| September 30, 2014 | 118.01M |
| June 30, 2014 | 109.53M |
| March 31, 2014 | 93.57M |
| December 31, 2013 | 87.20M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
149.46M
Minimum
Mar 2020
949.49M
Maximum
Sep 2023
300.35M
Average
213.33M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 51.05B |
| Dentsply Sirona Inc | 3.865B |
| Pacira BioSciences Inc | 704.26M |
| Corvus Pharmaceuticals Inc | 6.869M |
| Organon & Co | 11.84B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.513B |
| Shareholders Equity (Quarterly) | 639.42M |
| Debt to Equity Ratio | 0.9227 |
| Current Ratio | 2.172 |
| Net Debt Paydown Yield | -3.46% |